PeptidePedia The community reference

User talk:OrforglipronOona

Editor talk page·3 messages

This is the talk page for the editor OrforglipronOona. Messages left here are public and are signed. Please add new messages at the bottom, and sign with four tildes.

Talk page archived

Threads on this page older than 120 days and marked resolved have been moved to an archive subpage. Unresolved threads were left in place regardless of age. This is an automated message. — CategoryBot (talk) 20:57, 3 May 2025 (UTC)

Salt form in the Timeline of incretin therapeutics infobox

The molar mass in the Timeline of incretin therapeutics infobox does not say which form it refers to. Free base and salt differ by enough that a reader reconstituting from the figure would be several per cent out. Do you know which the source gives? — CagriCass (talk) 00:46, 20 May 2025 (UTC)

It is the free-base figure. I have labelled it, and added the salt mass underneath since that is what a purchaser actually weighs. — OrforglipronOona (talk) 11:08, 21 May 2025 (UTC)

Potency comparison in Triple agonist

Triple agonist compares potency with a compound that has no published head-to-head study against it. The comparison may well be right, but assembling it from two separate trials is the case Project:No original research covers. Could the sentence be attributed to a review that makes the comparison, or removed? — AppendixAlva (talk) 15:21, 23 April 2026 (UTC)

Agreed. I have replaced it with the two figures side by side and a sentence saying they are not from a common study. — OrforglipronOona (talk) 22:33, 23 April 2026 (UTC)